HCA HEALTHCARE ($HCA) posted quarterly earnings results for Q4 2025 on Tuesday, January 27th. The company reported earnings of $8.01 per share, beating estimates of $7.53 by $0.48. The company also reported revenue of $19,513,000,000, missing estimates of $19,862,585,896 by $-349,585,896.
You can see Quiver Quantitative's $HCA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HCA HEALTHCARE Insider Trading Activity
HCA HEALTHCARE insiders have traded $HCA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HCA stock by insiders over the last 6 months:
- MICHAEL R MCALEVEY (EVP & Chief Legal & Admin Off.) sold 3,892 shares for an estimated $1,843,990
- MICHAEL S. CUFFE (EVP and Chief Clinical Officer) sold 3,836 shares for an estimated $1,606,670
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HCA HEALTHCARE Hedge Fund Activity
We have seen 574 institutional investors add shares of HCA HEALTHCARE stock to their portfolio, and 587 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,465,455 shares (+74.5%) to their portfolio in Q3 2025, for an estimated $624,576,921
- LONGVIEW PARTNERS (GUERNSEY) LTD removed 1,287,869 shares (-82.4%) from their portfolio in Q3 2025, for an estimated $548,889,767
- PACER ADVISORS, INC. added 896,437 shares (+6115.3%) to their portfolio in Q3 2025, for an estimated $382,061,449
- PRICE T ROWE ASSOCIATES INC /MD/ removed 813,787 shares (-59.6%) from their portfolio in Q3 2025, for an estimated $346,836,019
- VANGUARD GROUP INC removed 580,889 shares (-3.8%) from their portfolio in Q3 2025, for an estimated $247,574,891
- VIKING GLOBAL INVESTORS LP removed 491,550 shares (-26.3%) from their portfolio in Q3 2025, for an estimated $209,498,610
- BLACKROCK, INC. removed 483,554 shares (-3.7%) from their portfolio in Q3 2025, for an estimated $206,090,714
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HCA HEALTHCARE Congressional Stock Trading
Members of Congress have traded $HCA stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HCA stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/19 and 1 sale worth up to $15,000 on 09/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HCA HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $HCA in the last several months. We have seen 11 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Underweight" rating on 12/15/2025
- Barclays issued a "Overweight" rating on 10/27/2025
- Truist Securities issued a "Buy" rating on 10/27/2025
- Oppenheimer issued a "Outperform" rating on 10/27/2025
- Mizuho issued a "Outperform" rating on 10/27/2025
- Keybanc issued a "Overweight" rating on 10/27/2025
- TD Cowen issued a "Buy" rating on 10/27/2025
To track analyst ratings and price targets for HCA HEALTHCARE, check out Quiver Quantitative's $HCA forecast page.
HCA HEALTHCARE Price Targets
Multiple analysts have issued price targets for $HCA recently. We have seen 17 analysts offer price targets for $HCA in the last 6 months, with a median target of $490.0.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $452.0 on 01/07/2026
- Ann Hynes from Mizuho set a target price of $520.0 on 12/18/2025
- Craig Hettenbach from Morgan Stanley set a target price of $425.0 on 12/15/2025
- Brian Tanquilut from Jefferies set a target price of $525.0 on 10/28/2025
- Andrew Mok from Barclays set a target price of $494.0 on 10/27/2025
- Joanna Gajuk from B of A Securities set a target price of $470.0 on 10/27/2025
- Andrew Mok from UBS set a target price of $525.0 on 10/27/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
